Umbilical Cord Pericytes Provide a Viable Alternative to Mesenchymal Stem Cells for Neonatal Vascular Engineering (2021)
Attributed to:
In vitro and in vivo preclinical testing of pericyte-engineered grafts for correction of congenital heart defects
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fcvm.2020.609980
PubMed Identifier: 33553259
Publication URI: http://europepmc.org/abstract/MED/33553259
Type: Journal Article/Review
Parent Publication: Frontiers in Cardiovascular Medicine
ISSN: 2297-055X